Recent advances in pathophysiology and current management of itch

Annals of the Academy of Medicine Singapore

Volumn 36, Issue 9, 2007, Pages 788-792

  Greaves, Malcolm W ^a,b,c,d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL SKIN CENTRE   (Singapore)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d Dovecote House   (United Kingdom)

Author keywords

Antipruritics; Neurophysiology; Pruritus

Indexed keywords

BUTORPHANOL; CORTICOSTEROID; GABAPENTIN; MIRTAZAPINE; NALTREXONE; NEUROTROPHIN; PAROXETINE; PLACEBO; THALIDOMIDE; VANILLOID RECEPTOR 1;

CLINICAL TRIAL; HUMAN; KIDNEY FAILURE; LOW DRUG DOSE; MAST CELL; NERVE STIMULATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRURITUS; REVIEW;

EID: 36849000287     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Greaves MW, Wall PD. Pathophysiology of itching. Lancet 1996;348:938-40.
2. Yosipovitch G, Greaves MW, Schmelz M. Itch. Lancet 2003;361:690-94.
3. Greaves MW, Khalifa N. Itch: more than skin deep. Int Arch Allergy Immunol 2004;135:166-72.
4. Inoue K, Koizumi S, Fuzuwara S, Denda S, Denda M. Functional vanilloid receptors in cultured normal human epidermal keratinocytes. Biochem Biophys Res Commun 2002;291:124-9.
5. Schmelz M. A neural pathway for itch. Nat Neurosci 2001;4:9-10.
6. Schmelz M, Hilliges M, Schmidt R, Orstavik K, Vahlquist C, Weidner C, et al. Active "itch fibers" in chronic pruritus. Neurology 2003;61:564-6.
7. Andrew D, Craig AD. Spinothalamic lamina 1 neurons selectively sensitive to histamine: a central neural pathway for itch. Nat Neurosci 2001;4:72-7.
8. Hsieh JC, Hagermark O, Stahle-Backdahl M. Urge to scratch represented in the human cerebral cortex during itch. J Neurophysiol 1994;72:3004-8.
9. McGlone F, Rukvveid R, Hitchcock D, Howard M. Histamine-induced discriminative and affective responses revealed by functional MRI. In: Yosipovitch G, Greaves MW, McGlone F, editors. Itch: Basic Mechanisms and Therapy. New York: Marcel Decker, 2004;51-61.
10. Wall PD, Melzack R. Textbook of Pain. 3rd ed. Edinburgh: Churchill Livingstone, 1995.
11. Togashi Y, Umeuchi H, Okano K, Ando N, Yoshizawa Y, Honda T, et al. Antipruritic activity of the kappa-opioid receptor agonist, TRK-820. Eur J Pharmacol 2002;435:259-64.
12. Wall PD, Sweet WH. Temporary abolition of pain in man. Science 1967;155:108-9.
13. Davies MG, Greaves MW. Sensory responses of human skin to synthetic histamine analogues and histamine. Br J Clin Pharmacol 1980;9:461-5.
14. Bell JK, McQueen DS, Rees JL. Involvement of histamine H4 and H1 receptors in scratching induced by histamine receptor agonists in Balb C mice. Br J Pharmacol 2004;142:374-80.
15. Steinhoff M, Vergnolle NM, Young SH, Tognetto M, Amadesi S, Ennes HS. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med 2000;6:151-8.
16. Toyoda M, Nakamura M, Makino T, Hino T, Kagoura M, Morohashi M. Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol 2002;147:71-9.
17. Szallasi A, Blumberg PM. Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev 1999;51:159-212.
18. Southall MD, Li T, Gharibova LS, Pei Y, Nicol GD, Travers JB. Activation of epidermal vanilloid rcceptor-1 induces release of proinflammatory mediators in human keratinocytes. J Pharmacol Exp Ther 2003;304:217-22.
19. McKemy DD, Neuhasser WM, Julius D. Identification of a cold receptor reveals a general role for TRP channels in thermosensation. Nature 2002;416:52-8.
20. Twycross R, Greaves MW, Handwerker H, Jones EA, Libretto SE, Szepietowski JC, et al. Itch: scratching more than the surface. QJM 2003;96:7-26.
21. Heyer G, Dotzer M, Diepgen TL. Opiate and H1 antagonist effects on histamine induced pruritus and alloknesis. Pain 1997;73:239-43.
22. Ballantyne JC, Loach AB, Carr DB. Itching after epidural and spinal opiates. Pain 1988;33:149-60.
23. Bergasa NV, Sabol SL, Yound WS, Kleiner DE, Jones EA. Cholestasis is associated with preproenkephalin mRNA expression in the adult rat liver. Am J Physiol 1995;268(2 pt 1):G346-54.
24. Bergasa NV, Talbot TL, Alling DW, Schmitt JM, Walker EC, Baker BL. et al. A controlled trial of naloxone infusions for the pruritus of chronic cholestasis. Gastroenterology 1992;102:544-9.
25. Ghent CN, Carruthers SG. Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind crossover trial. Gastroenterology 1988;94:488-93.
26. Fantini F, Baraldi A, Serignani C, Spattini A, Pincelli C, Giannetti A. Cutaneous innervation in chronic renal failure patients. An Immunohistochemical study. Acta Dermatol Venereol 1992;72:102-5.
27. Kimmel M, Alscher DM, Dunst, R, Braun N, Machleidt C, Kiefer T, et al. The role of micro-inflammation in the pathogenesis of uracmic pruritus in haemodialysis patients. Nephrol Dial Transplant 2006;21:749-55.
28. Pauli-Magnus C, Klumpp S, Alscher DM, Kuhlmann U, Mettang T. Short-term efficacy of tacrolimus ointment in severe uraemic pruritus. Perit Dial Int 2000;20:802-3.
29. Gunal AI, Ozalp G, Yoldas TK, Gunal SY, Kirciman E, Celiker H. Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled double-blind trial. Nephrol Dial Transplant 2004;19:3137-9.
30. Fruhstorfer H, Hermanns M, Latzke L. The effects of thermal stimulation on clinical and experimental itch. Pain 1986;24:259-69.
31. Wei ET, Seid DA. AG-3-5: a chemical producing sensations of cold. J Pharm Pharmacol 1983;35:110-2.
32. Chung MK, Lee H, Mizuno A, Suzuki M, Caterina MJ. TRPV3 and TRPV4 mediate warmth-evoked currents in primary mouse keratinocytes. J Biol Chem 2004;279:21569-75.
33. Wallengren J, Sundler F. Cutaneous field stimulation in the treatment of severe itch. Arch Dermatol 2001:137:1323-5.
34. Gilchrcst BA, Rowe JW, Brown RS, Steinman TI, Arndt KA. Ultraviolet phototherapy of uremic pruritus. Long-term results and mechanism of action. Ann Intern Med 1979;91:17-21.
35. Figueiredo A, Ribeiro A, Goncalo M, Almeida L, Poaires-Batitsta A, Texcira F. Mechanism of action of doxepin in the treatment of chronic urticaria. Fundam Clin Pharmacol 1990;4:147-58.
36. Metze D, Reimann S, Beissert S, Luger T. Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases. J Am Acad Dermatol 1999;41:533-59.
37. Dawn AG, Yosipovitch G. Butorphanol for treatment of intractable pruritus. J Am Acad Dermatol 2006;54:527-31.
38. Davis MP, Frandsen JL, Walsh D, Andresen S, Taylor S, et al. Mirtazapine for pruritus. J Pain Symptom Manage 2003;25:288-91.
39. Zylicz Z, Krajnik M, Sorge AA, Constantini M. Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial. J Pain Symptom Manage 2003;26:1105-12.
40. Daly BM, Shuster S. Antipruritic action of thalidomide. Acta Derm Venereol 2000;80:24-5.